Based on the complex role of an IDH1 mutation in progression, aggressive biological behavior and response to therapy of malignant diffuse gliomas, it appears reasonable to dissect the molecular mechanisms underlying the less aggressive phenotype and increased sensitivity to radiation of IDH1R132H-gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.